GoldenExo® NFSA
A high-dose, lyophilized UC-MSC extracellular vesicle material designed for professional research and formulation programs involving inflammatory balance, metabolic homeostasis and tissue-repair pathways.
Quick Facts
- Native MSC-EV Lyophilized Material
- Particle Content: 1.0E11 particles / vial
- Presentation: Lyophilized
- Storage: 2-8°C
- Shipping: Ambient or ice-pack
- Source: Human UC-MSC
- COA
- TDS
- SDS
- Formulation Support
A high-dose GoldenExo® material built around systemic research questions.
NFSA retains a naturally complex MSC-EV cargo profile for multi-pathway systemic homeostasis, inflammatory-balance and repair-related research rather than a single-target mechanism.
Full-Spectrum Native Cargo: A naturally complex EV cargo profile supporting multi-pathway research rather than a single-target mechanism.
Defined High-Dose Presentation: A 100 billion-particle format suitable for dose exploration, formulation screening and comparative studies.
Lyophilized Convenience: Refrigerated storage and flexible shipping simplify project planning and international sample logistics.
Systemic Research Versatility: Applicable to systemic and local delivery-development studies across metabolic, inflammatory and repair-related models.
Evaluation pathway designed around product use
01 Source & Cell Bank: Confirm source, cell identity and batch traceability.
02 Culture & Harvest: Control culture system and harvest window by product positioning.
03 Purification & Concentration: Match purification strategy to lyophilized, frozen or formulation-development needs.
04 Fill & Storage: Define specification, packaging and shipping conditions.
05 Quality Evaluation: Combine EV identity, purity, safety and functional tests by project.
06 Application Support: Connect to formulation, delivery, model validation and co-development.
From Material Identity to Application-Relevant Performance
Source Identity & Traceability: Documented human UC-MSC or defined producer-cell sourcing; Cell-bank identity and batch records; Project-appropriate traceability and source controls
Controlled Manufacturing: Defined culture, harvest and purification workflows; Lyophilized or cryopreserved presentation by product design; Batch consistency and scale-up compatibility
Orthogonal Quality Evaluation: Particle concentration, size and EV identity; Purity, membrane integrity and safety tests; Functional or stability assays selected by project
Batch-Level Documentation: COA, TDS and SDS supplied by project scope; Connection to formulation development and further manufacturing; Support for technical review and collaboration planning
Product-specific analytical focus: For NFSA projects, particle concentration, EV identity, purity, membrane integrity, safety and functional activity can be combined into a project-specific analytical package.
Where the Product Can Fit
Inflammatory Balance: Research into coordinated regulation of chronic inflammatory signaling and immune homeostasis.
Tissue-Repair Signaling: Study of endogenous repair, migration and microenvironment-support pathways.
Cellular Stress Response: Exploration of oxidative-stress and cellular resilience-related EV signaling.
Metabolic Homeostasis: Investigation of energy sensing, nutrient utilization and metabolic communication.
Intercellular Communication: A native lipid-membrane carrier for multi-component signal delivery research.
Formulation Development: A concentrated starting material for route, dose and excipient compatibility studies.
Key Information for Technical Evaluation
Product Name: GoldenExo® NFSA
Material Type: Human UC-MSC-derived extracellular vesicles / exosomes
Particle Content: 1.0E11 particles / vial
Presentation: Lyophilized
Storage: 2-8°C
Shipping: Ambient or ice-pack
Application: Inflammatory balance, metabolic homeostasis, tissue repair and systemic homeostasis research
Collaboration: Standard supply, formulation development, OEM / ODM / CDMO evaluation
Final specification, storage, shipping and handling requirements are governed by the batch label, COA, TDS and confirmed project documentation.
From Product Supply to Co-Development
Standard Material Supply: Deliver material and agreed documentation according to product specification.
Formulation & Delivery Development: Evaluate concentration, excipients, packaging and application format.
Quality & Stability Research: Extend analytics, stability and model validation by project.
OEM / ODM / CDMO: Connect raw material, prototype and further manufacturing collaboration.
FAQ
- What is GoldenExo® NFSA?
- NFSA is a lyophilized UC-MSC-derived extracellular vesicle raw material supplied in a defined 1.0E11-particle presentation for professional research, formulation development and further manufacturing.
- What distinguishes NFSA from the flagship NATX product?
- NFSA is positioned as a versatile full-spectrum native MSC-EV material. NATX is the higher-dose flagship presentation with a broader premium quality and application package.
- Can the formulation or particle concentration be customized?
- Project-specific concentration, presentation and formulation-development requirements can be evaluated through Echo Biotech's OEM, ODM and CDMO collaboration pathways.
- Is NFSA intended for direct clinical use?
- No. The material is supplied for research, formulation development or further manufacturing under the applicable agreement and regulatory framework.